Zobrazeno 1 - 10
of 23
pro vyhledávání: '"Lela Bitar"'
Autor:
Dragan Trivanović, Željka Peršurić, Andrea Agaj, Marko Jakopović, Miroslav Samaržija, Lela Bitar, Krešimir Pavelić
Publikováno v:
International Journal of Molecular Sciences, Vol 23, Iss 23, p 15067 (2022)
Patients with cancer are more susceptible to a higher risk of coronavirus infection and its severe complications than the general population. In addition, these patients were not included in the pivotal clinical trials for COVID-19 vaccines. Therefor
Externí odkaz:
https://doaj.org/article/9e4af50728204b6f85b7bd23fc0ab0df
Autor:
Josip Vincelj, Lela Bitar
Publikováno v:
Health and Quality of Life Outcomes, Vol 18, Iss 1, Pp 1-1 (2020)
Abstract We have read the article titled „Quality of life 10 years after cardiac surgery in adults: a long-term follow-up study “ by Perrotti A. et al. published in your distinguished journal with great interest. Unfortunately, we found few error
Externí odkaz:
https://doaj.org/article/943271b14e1b4a33b962221d92c8605d
Autor:
Ana Bačelić-Gabelica, Sonja Badovinac, Fran Seiwerth, Miroslav Samaržija, Dražena Srdić, Lela Bitar, Lidija Ljubičić, Sanja Pleština, Marko Jakopović, Marta Koršić
Publikováno v:
Lung cancer.
Autor:
Kristina Krpina, Marko Jakopović, Ante Marušić, Miroslav Samarzija, Fran Seiwerth, Lela Bitar
Publikováno v:
J Thorac Dis
Thymic epithelial tumors (TETs) are rare thymic neoplasms. There are approximately 1.5 cases per million TETs per year. They are the most common anterior mediastinal tumors in adults. Due to limited activity of available treatment options novel strat
Autor:
Lela Bitar, Sven Seiwerth, Dinko Stancic Rokotov, Fran Seiwerth, Luka Brcic, Suzana Kukulj, Zoran Janevski, Gzim Redžepi, Feđa Džubur, Tomislav Dujmović, Goran Glodić, Miroslav Samaržija, Anton Mažuranić, Željko Djaković, Mateja Jankovic Makek, Antun Koprivanac, Ante Marušić, Sanja Pleština, Marko Jakopović
Publikováno v:
Liječnički vjesnik. 142
Malignant pleural mesothelioma (MPM) is an aggressive tumor that develops from the mesothelial cells lining the pleural cavity. The most relevant risk factor is asbestos exposure. Despite therapy the median survival is poor ranging from four to 18 mo
Autor:
Eduard Vrdoljak, Miroslav Samaržija, Lajos Géczi, Claude Magri, Krisztina Bogos, Marko Jakopović, Žarko Bajić, Lela Bitar, Lidija Bošković
Publikováno v:
Journal of Oncology
Journal of Oncology, Vol 2020 (2020)
Journal of Oncology, Vol 2020 (2020)
Background. There is a lack of real-world data on the safety and efficacy of nivolumab in patients with previously treated advanced non-small-cell lung cancer (NSCLC) especially in South East Europe, a region with particularly high incidence and an u
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b45067c1c36061ab31fc465ceb484991
https://doi.org/10.21203/rs.3.rs-24643/v1
https://doi.org/10.21203/rs.3.rs-24643/v1
Autor:
Goran Glodić, Antun Koprivanac, Anton Mažuranić, Tomislav Dujmović, Ante Marušić, Sanja Pleština, Suzana Kukulj, Lela Bitar, Fran Seiwerth, Sven Seiwerth, Luka Brčić, Dinko Stančić Rokotov, Zoran Janevski, Željko Djaković, Feđa Džubur, Mateja Janković Makek, Gzim Redžepi, Miroslav Samaržija, Marko Jakopović
Publikováno v:
Liječnički vjesnik
Volume 142
Issue 9-10
Volume 142
Issue 9-10
Maligni pleuralni mezoteliom rijetka je i agresivna primarna novotvorina mezotelnih stanica pleure. Glavni rizični čimbenik je izloženost azbestu, najčešće uz latenciju od 30–50 godina. Unatoč terapiji medijan preživljenja je od 4 do 18 mje
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::c904e9da2b1cda8feb2a0c3de1be5d91
https://doi.org/10.26800/lv-142-9-10-47
https://doi.org/10.26800/lv-142-9-10-47
Autor:
Marta Korsic, Silvana Smojver-Jezek, Sonja Badovinac, Marko Jakopović, Mihovil Roglić, Bozica Vrabec Branica, Lela Bitar
Publikováno v:
Interventional pulmonology.
Introduction: Tissue sampling of peripheral pulmonary neoplasms for patohistology and analysis of prognostic biomarkers can be challenging. Radial endobronchial ultrasound (R-EBUS) is one of the modern bronchoscopic modalities used for more precise l
Autor:
Marko Jakopović, S. Smojver Ježek, Kristina Krpina, Miroslav Samaržija, Fran Seiwerth, G. Glodić, A. Mataić, Lela Bitar, F. Džubur, Ivona Markelić
Publikováno v:
Journal of Thoracic Oncology. 16:S1075
Autor:
Drazena Srdic, Miroslav Samaržija, F. Džubur, Marko Jakopović, L. Batelja Vuletic, S. Smojver Ježek, G. Glodić, Lela Bitar, Fran Seiwerth
Publikováno v:
Journal of Thoracic Oncology. 16:S1093